Advanced Medical Isotope Corporation (AMIC) 

We're a Washington State based company comprised of a brilliant team of radio-chemists, scientists and engineers, collaborating with national labs and universities to implement proprietary technologies capable of producing crucial medical isotopes on US soil.

By enabling physicians and empowering researchers to find isotope solutions, we are
helping to lengthen the lives of Cancer patients and creating hope for a healthier
future.

Worldwide Isotope Shortage Problem?

"Critical shortage of Molybdenum-99 and its derivative, Technetium-99m, the most commonly used medical radioisotope in the world – used in 50,000 diagnostic medical procedures in the US every day"

  Real Time Stock Quote  

  Keep in touch with us  

  News from Advanced Medical Isotope Corporation  

AMIC Enters Into Strategic Alliance with GSG International

KENNEWICK, Wash. – March 26, 2013 (GLOBE NEWSWIRE) – Advanced Medical Isotope Corporation (“AMIC”) (OTCBB: ADMD), a company engaged in the production and distribution of medical isotopes, has entered into a strategic alliance with GSG International GMbH to collaborate in the joint development of technologies for the production of medical isotopes and the marketing and distribution of related isotopes, equipment and services.

The first endeavor of the strategic alliance (“Alliance”) will be the worldwide distribution of Molybendum-99 (Mo-99) and related Technetium-99 generators and kits acquired or manufactured by GSG on behalf of the Alliance.  AMIC initially will have exclusive rights for sale and distribution in North America, South America and China.  Subject to the parties’ performance, AMIC may thereafter obtain additional rights.

The Company and GSG also are commencing a technical review of their respective technologies, rights and business lines to determine the other products and services to be included in their Alliance. 

GSG is the Switzerland-based member of Gamma Service Group International, an innovative provider of advanced services, equipment and solutions for production and handling of radionuclide materials with operations in Switzerland, Germany and Russia.

Read more...

Advanced Medical Isotope Corporation has Solutions. 

AMIC's scientific team aims to create a reliable, domestic Mo-99 supply and
distribution system:

AMIC's approach is two-fold:

1. AMIC's Proprietary Hybrid Accelerator is a subcritical assembly system.
2. Potential AMIC-MURR Joint Venture (“Mo Moly”) utilize existing 
   Missouri University Research Reactor to produce Mo-99.

Each Solution set has the potential to provide up to 50% of U.S. domestic requirements of Mo-99.

• 30 million procedures per year worldwide use Technetium-99 / Molybdenum-99      
                                                       ~ World Nuclear Association, October 2011